Breaking News

Touchlight Expands mbDNA Platform

Introduces three new circular DNA architectures.

Author Image

By: Charlie Sternberg

Associate Editor

Touchlight, a provider of cell-free DNA technology, has expanded its mbDNA platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA. These constructs join mbDNA, which debuted earlier this year, to form a comprehensive portfolio designed to overcome the limitations of traditional gene editing tools. The mbDNA platform and new custom circle DNA architectures deliver enhanced stability, reduced immunogenicity, and compatibility with a broad range of ge...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters